This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Pharmathen S.a.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Aristotelis Menisiou: Innovator in Pharmaceutical Chemistry
Introduction
Aristotelis Menisiou is a notable inventor based in Salonika, Greece. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for drug synthesis. His work has implications for the production of important medicinal compounds.
Latest Patents
Menisiou holds a patent for a process related to the preparation of a propenal intermediate and its derivatives. The patent, titled "Process for the preparation of a propenal intermediate and derivatives thereof," outlines an improved method for synthesizing a key intermediate used in the production of Rosuvastatin, a widely used cholesterol-lowering medication. This patent highlights his innovative approach to enhancing pharmaceutical manufacturing processes.
Career Highlights
Aristotelis Menisiou is associated with Pharmathen S.A., a prominent company in the pharmaceutical industry. His role at Pharmathen has allowed him to apply his expertise in drug development and contribute to the advancement of therapeutic solutions. His work is characterized by a commitment to improving the efficiency and effectiveness of pharmaceutical processes.
Collaborations
Menisiou has collaborated with esteemed colleagues such as Theoharis V. Koftis and Thanos Andreou. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the pharmaceutical sector.
Conclusion
Aristotelis Menisiou's contributions to pharmaceutical chemistry, particularly through his patent and work at Pharmathen, underscore his role as an influential inventor in the industry. His innovative processes are paving the way for advancements in drug synthesis and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile